TAKEHARA Kosuke 竹原浩介

… Alternative Names

TAKEHARA Kousuke 竹原浩介

Less

Researcher Number	40580345
Affiliation (based on the past Project Information) *help	2017: 長崎大学, 病院(医学系), 講師 2015 – 2017: 長崎大学, 医歯薬学総合研究科(医学系), 客員研究員 2013: 長崎大学, 病院, 助教 2011 – 2013: 長崎大学, 大学病院, 助教
Review Section/Research Field	Principal Investigator Urology Except Principal Investigator Urology
Keywords	Principal Investigator T24 / Fer / 遊走能 / 細胞遊走 / 細胞浸潤 / 細胞増殖 / 膀胱癌 / 化学療法 / TUBB3 / 予後 … More / 癌細胞浸潤 / 癌細胞増殖 / 尿路癌 / Fes … More Except Principal Investigator 治療標的 / 腎細胞癌 / 機能解明 / 癌関連分子同定 / 肉腫様腎癌 / 標的分子 / 予後不良因子 / 肉腫様腎細胞癌 / PC-3細胞 / ﾐｯﾄﾞｶｲﾝ / LNCaP細胞 / 自然炎症 / ミッドカイン / 前立腺癌 Less

Investigation on usefulness of Fes / Fer as new therapeutic target and predictive factor in urothelial cancerPrincipal Investigator
- Principal Investigator
  
  TAKEHARA Kosuke
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Nagasaki University
Evaluation of usefulness of sarcomatoid renal cell carcinoma experiment model using clinical specimen data and search for new therapeutic targets.
- Principal Investigator
  
  MOCHIZUKI Yasushi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Nagasaki University
Analysis of the role of Midkine in prostate cancer progression based on homeostatic inflammation
- Principal Investigator
  
  TSUKASA IGAWA
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Nagasaki University

All 2018 2017 2014 2013 2011 Other

All Journal Article Presentation

[Journal Article] Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line Chemotherapy.2018
- Author(s)
  Miyata Y, Matsuo T, Nakamura Y, Yasuda T, Ohba K, Takehara K, Sakai H.
- Journal Title
  
  Anticancer Research
  
  Volume: 38 Pages: 1629-1635
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K10594
[Journal Article] Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.2018
- Author(s)
  Asai A, Miyata Y, Takehara K, Kanda S, Watanabe SI, Greer PA, Sakai H.
- Journal Title
  
  Journal of Cancer Research and Clinical Oncology
  
  Volume: １４４ Issue: 1 Pages: 21-31
- DOI
  10.1007/s00432-017-2524-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K10594
[Journal Article] Stability of [－2]Pro-PSA in Whole Blood and Serum: Analysis for Optimal Measurement Conditions2014
- Author(s)
  Tsukasa Igawa, Kosuke Takehara, Toru Onita, Kazuto Ito, and Hideki Sakai
- Journal Title
  
  Journal of Clinical Laboratory Analysis
  
  Volume: 00 Issue: 4 Pages: 1-5
- DOI
  10.1002/jcla.21687
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23592336
[Journal Article] Stability of [-2]pro-PSA in whole-blood and serum : analysis for optimal measurement conditions2013
- Author(s)
  Igawa T, Takehara K, Onita T, Ito K, Sakai H
- Journal Title
  
  Journal of Clinical Laboratory Analysis
  
  Volume: (in press) Issue: 4 Pages: 275-280
- DOI
  10.1002/jcla.21678
- Data Source
  KAKENHI-PROJECT-23592336
[Presentation] Pathological significance and prognostic roles of FES expression in bladder cancer2017
- Author(s)
  Akihiro Asai, Yasuyoshi Miyata, Kosuke Takehara, Shigeru Kanda, Shin-ichi Watanabe, Hideki Sakai
- Organizer
  European Association of Urology, Annual Meeting 2017
- Place of Presentation
  ロンドン（イギリス）
- Year and Date
  2017-03-24
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10594
[Presentation] 前立腺癌根治手術後のPSA再発に対する間欠的内分泌療法の有用性の検討2011
- Author(s)
  井川　掌、竹原浩介、大仁田亨、酒井英樹
- Organizer
  第49回日本癌治療学会年次総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23592336
[Presentation] The impact of intermittent androgen deprivation therapy for biochemical failure after radical prostatectomy2011
- Author(s)
  Tsukasa Igawa, Kosuke Takehara, Toru Onita, Hideki Sakai
- Organizer
  2011 SIU annual meeting
- Place of Presentation
  Berlin
- Data Source
  KAKENHI-PROJECT-23592336
[Presentation] 前立腺全摘術後PSA再発に対する間歇的ホルモン療法の臨床的検討
- Author(s)
  井川　掌、竹原浩介、大仁田　亨、酒井英樹
- Organizer
  第51回日本癌治療学会総会
- Place of Presentation
  京都市　国際会議場
- Data Source
  KAKENHI-PROJECT-23592336
[Presentation] [-2]pro-PSAの採血検体での測定安定性に関する検討
- Author(s)
  井川　掌、松尾朋博、竹原浩介、大仁田　亨、酒井英樹
- Organizer
  第101回日本泌尿器科学会総会
- Place of Presentation
  札幌市　ロイトン札幌
- Data Source
  KAKENHI-PROJECT-23592336

1. MOCHIZUKI Yasushi (40404256)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
2. 宮田康好 (60380888)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
3. TSUKASA IGAWA (40295069)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
4. SAKAI Hideki (40235122)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
5. ONITA Toru (50452850)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
6. NAKANISHI Hiromi

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. NAKAMURA Yuichiro

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. ARAKI Kyohei

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

TAKEHARA Kosuke 竹原 浩介

TAKEHARA Kousuke 竹原 浩介

Research Projects

Research Products

Co-Researchers

Investigation on usefulness of Fes / Fer as new therapeutic target and predictive factor in urothelial cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Evaluation of usefulness of sarcomatoid renal cell carcinoma experiment model using clinical specimen data and search for new therapeutic targets.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of the role of Midkine in prostate cancer progression based on homeostatic inflammation

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line Chemotherapy.2018

Author(s)

Journal Title

Data Source

[Journal Article] Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Stability of [－2]Pro-PSA in Whole Blood and Serum: Analysis for Optimal Measurement Conditions2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Stability of [-2]pro-PSA in whole-blood and serum : analysis for optimal measurement conditions2013

Author(s)

Journal Title

DOI

Data Source

[Presentation] Pathological significance and prognostic roles of FES expression in bladder cancer2017

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 前立腺癌根治手術後のPSA再発に対する間欠的内分泌療法の有用性の検討2011

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] The impact of intermittent androgen deprivation therapy for biochemical failure after radical prostatectomy2011

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 前立腺全摘術後PSA再発に対する間歇的ホルモン療法の臨床的検討

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] [-2]pro-PSAの採血検体での測定安定性に関する検討

Author(s)

Organizer

Place of Presentation

Data Source

TAKEHARA Kosuke 竹原浩介

TAKEHARA Kousuke 竹原浩介